Osta Biotechnologies - Grant Awarded
August 18, 2009
Prostate Cancer Canada Grants Award to Osta's Principal Investigator.
Osta Biotechnologies Inc. (TSXV:OBI) today announced that its principal investigator for the pre-clinical studies on its cancer program, Dr. Moulay Alaoui-Jamali has been awarded a grant of $60,000 by Prostate Cancer Canada, a Canadian National Foundation dedicated to the elimination of prostate cancer through research, education, support and awareness. This award has been granted to advance the basic science behind HO-1 signaling in hormone refractory prostate cancer. This research will have potential long-term implications for understanding the impact of Osta's novel HO-1 inhibitors on HO signaling and advanced prostate cancer. This study is conducted in collaboration with Dr. Ajay Gupta, Osta Biotechnologies; Dr. Walter A. Szarek, a Professor Emeritus, Department of Chemistry, Queen's University, Kingston, Ontario; Dr. Tarek Bismar, an Associate Professor at the Southern Alberta Cancer Institute, Departments of Pathology & Laboratory Medicine and Oncology, University of Calgary, Alberta and Dr. Hyman M. Schipper, a Professor at the Department of Neurology and Medicine at the Jewish General Hospital and McGill University.
Read the article